Anika Therapeutics Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
35.33
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.25
|
-0.29
|
-0.04
|
-16.00%
|
|
2022-06-30
|
-0.23
|
-0.20
|
0.03
|
13.04%
|
|
2022-03-31
|
-0.36
|
-0.20
|
0.16
|
44.44%
|
|
2021-12-31
|
-0.25
|
-0.40
|
-0.15
|
-60.00%
|
|
2021-09-30
|
-0.21
|
0.04
|
0.25
|
119.05%
|
|
2021-06-30
|
-0.15
|
0.45
|
0.60
|
400.00%
|
|
2021-03-31
|
-0.12
|
0.20
|
0.32
|
266.67%
|
|
2020-12-31
|
0.14
|
-1.10
|
-1.24
|
-885.71%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.69
|
|
2021-12-31
|
0.29
|
|
2020-12-31
|
-1.85
|
|
2019-12-31
|
1.91
|
|
2018-12-31
|
1.29
|
|
2017-12-31
|
1.97
|
|
2016-12-31
|
2.15
|
|
2015-12-31
|
2.01
|
|
2014-12-31
|
2.48
|
|
2013-12-31
|
1.37
|
|
2012-12-31
|
0.94
|
|
2011-12-31
|
0.62
|
|
2010-12-31
|
0.32
|
|
2009-12-31
|
0.32
|
|
2008-12-31
|
0.32
|
|
2007-12-31
|
0.54
|
|
2006-12-31
|
0.41
|
|
2005-12-31
|
0.51
|
|
2004-12-31
|
0.37
|
|
2003-12-31
|
-0.30
|
|
2001-12-31
|
-0.68
|
|
2000-12-31
|
0.01
|
|
1999-12-31
|
0.11
|
|
1998-12-31
|
0.42
|
|
1997-12-31
|
0.34
|